ghk cu peptide clinical evidence Excellent article on both topical and systemic peptides, just missing melanotan information! Very well written by Macrene Alexiades, MD, PhD @drmacrene in @gohealio newsletter. I'm often asked about copper GHK-Cu peptide. Here GHK-Cu Peptide Therapy: The Definitive

Its ability to penetrate the BBB, its metabolic stability, and its significant efficacy in restoring cognitive and motor functions in animal models of AD and PD, likely through modulating the HGF/c-Met system, position it as a highly promising therapeutic candidate for these debilitating neurodegenerative diseases [2]

It is truly a great and helpful piece of info

[DOI] [PMC free article] [PubMed] [Google Scholar] 247.Schmeisser, K

COMIRNATY (COVID-19 Vaccine, mRNA) and the Pfizer-BioNTech COVID-19 Vaccine intended for individuals 12 years of age and older should not be used for individuals 6 months through 11 years of age because of the potential for vaccine administration errors, including dosing errors

This finding is clinically significant for a patient population like ours in Doral, where the majority of patients present with Fitzpatrick III, IV, and V skin tones